StonvexLoading…
StonvexStonvexStonvexCore line items from OBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $109.35M | $131.30M | $537.96M | $403.32M | $267.18M |
Operating Income | Not available | $35.28M | $95.64M | $58.19M | $47.21M |
Net Income | Not available | $27.69M | $75.20M | $45.68M | $14.65M |
EPS (Diluted) | $1.01 | $0.89 | $2.40 | $1.46 | $1.18 |
Total Assets | Not available | $10.19B | $9.72B | $9.79B | $9.68B |
Total Liabilities | Not available | $8.93B | $8.48B | $8.58B | $8.47B |
Cash & Equivalents | Not available | $666.20M | $424.22M | $626.91M | $334.11M |
Free Cash Flow OCF − CapEx | Not available | $47.91M | $151.05M | $111.19M | $54.42M |
Shares Outstanding | Not available | 31.20M | 31.33M | 31.38M | 31.38M |